Irbesartan Tablet
Product Images NDC 50090-2017

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 50090-2017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartanfigure3.jpg (Irbesartanfigure3)

The text is a chart displaying the cumulative event rates for two groups within a study over a period of 60 months. The two groups are labeled "placebo" and "Ariadipne". The percentages represent the cumulative event rate for each group. It is not clear what the study was looking at or what type of events were being measured.*

FDA Label Image

Image2 (Camber1)

FDA Label Image

Image1 (Image1)

FDA Label Image

Image2 (Image2)

FDA Label Image

Lbl500901284

FDA Label Image

Label Image (Lbl500902017)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.